August 12, 2015
OrthoGrid Systems to Host Sessions at September ICJR Conference
(Salt Lake City, UT.)—OrthoGrid Systems, Inc. today announced the company will host
sessions with its increasingly popular HipGrid™ fluoroscopic radiopaque guide in both the
exhibit hall and cadaver lab for attendees of the International Congress for Joint
Reconstruction (ICJR) conference September 24-26, 2015 in Houston, Texas.
Our product specialists will be on hand to guide interested attendees on the simple and effective use of HipGrid™ starting September 24, 2015. VIEW ICJR SCHEDULE
About HipGrid™
Efficient, affordable and a clinical proven option for intraoperative navigation, HipGrid™ is
an FDA-approved, Class I, medical device available in the U.S. and works with standard low-
dose radiation C-arms available in most operating rooms. The non-invasive measurement
system was invented by orthopedic surgeons. It is clinically proven to assure proper
implant positioning and equal leg length post-surgery. HipGrid™ requires minimal setup
time, no additional personnel and no extensive training. It proves cost-effective for
surgeons and hospitals seeking to provide an accountable care environment. Orthopedic
surgeons may choose from two distinct grid patterns, HipGrid TearDrop Target™ (9”) device
or HipGrid TearDrop Vector™ (12”) device, based on surgical and fluoroscopic preference.
About OrthoGrid Systems, Inc.
OrthoGrid® Systems, Inc. is a privately owned medical device company based in Salt Lake
City, Utah. Its focus is inventing more accurate and cost-effective ways to assist in proper
positioning of implants and restoration of leg length when performing total hip replacement.
OrthoGrid® supplies a growing portfolio of patented and patent-pending technologies
related to intraoperative alignment using radiopaque grid patterns for orthopedic total joint
arthroplasty and trauma. Please visit company website for more information: www.OrthoGrid.com.
OrthoGrid®Systems, Inc.
Tonya Trest, VP Sales
Phone: 972.773.9981
Source: OrthoGrid, Inc.